The Technoscience Pontine Science and Technology Park Consortium officially joins the Sistema Invitalia Startup network, the national network promoted by Invitalia that brings together incubators, science parks, universities, research centres and organisations involved in supporting the creation and growth of innovative companies.
The entry was formalised through a communication from Head of the Service Promotion and Business Support Organisational Unit at Invitalia, who welcomed Technoscience, highlighting the importance of collaboration in strengthening guidance, support, training, networking and access to funding instruments for companies.
The satisfaction of the Director General
Great satisfaction was expressed by the Technoscience Director General, Eng. Stefano Di Rosa.
"Joining the Sistema Invitalia Startup network represents recognition of the work Technoscience has been carrying out for years in support of innovation, research and business growth. This membership will enable us to further strengthen our network of institutional relationships and offer startups, SMEs and young entrepreneurs new opportunities for development, support and access to national innovation instruments. We thank Invitalia for the trust it has placed in us and are ready to contribute actively to the growth of the network with expertise, project capabilities and a spirit of collaboration."
New opportunities for startups, SMEs and young entrepreneurs
Membership of the Sistema Invitalia Startup will enable Technoscience to take part in national initiatives dedicated to the innovation ecosystem, develop new collaborations with network partners and make an even broader range of services for business creation and development available to the local area.
A further step that consolidates the role of Technoscience as a reference point for technology transfer, innovation and support for the competitiveness of Italy's productive system.
How we turn ideas into biotech projects
Would you like to understand how we could work together on complex biotech projects, such as the one on glioblastoma? Below is a selection of in-depth pages on biopharmaceutical pipelines, biobanks, data management and AI, telemedicine, precision cardiology and TRL pathways. They are the starting point for turning a good idea into an operational pathway, from the initial concept through to clinical validation and market entry.
Careers & Skills
Industry & Technology Transfer
GREEN & AGRI-BIOTECH
Biopharmaceuticals & Therapies
Biotechnology for Health
Frequently Asked Questions
Biotech FAQ
The questions you ask us most often
It is an approach that defines the the actual biology of the disease (tissues, markers and omics profiles where indicated) and links it to diagnostic and therapeutic decisions diagnostic and therapeutic personalised. It does not stop at generic classifications or guidelines applied wholesale: it builds a individual pathway measurable through robust clinical endpoints.
An enabling role. The biobanks ensure traceable and comparable samples; the omics broaden the understanding of the underlying mechanisms (inflammatory, metabolic and genetic). When integrated with rigorous protocols and real-world data, make reproducible the evidence and accelerate translation towards clinical trials or clinical adoption.
